Nicole Renee Leboeuf, M.D.
Co-Author
This page shows the publications co-authored by Nicole Leboeuf and Cecilia Larocca.
Connection Strength
3.607
-
Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem. Clin Cancer Res. 2019 12 15; 25(24):7272-7274.
Score: 0.885
-
Overview of Cutaneous T-Cell Lymphomas. Hematol Oncol Clin North Am. 2019 08; 33(4):669-686.
Score: 0.861
-
Cutaneous Malignancy. Hematol Oncol Clin North Am. 2019 02; 33(1):xv-xvi.
Score: 0.843
-
Cutaneous Langerhans cell histiocytosis in adults: A retrospective cohort study of adult patients presenting to a single academic cancer center between 2003 and 2017. J Am Acad Dermatol. 2021 Jun 11.
Score: 0.248
-
An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions. Am J Clin Dermatol. 2020 Dec; 21(6):821-832.
Score: 0.239
-
De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis. J Am Acad Dermatol. 2021 Mar; 84(3):864-869.
Score: 0.238
-
De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation. Clin Exp Dermatol. 2021 Mar; 46(2):328-337.
Score: 0.237
-
Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res. 2020 01 15; 26(2):408-418.
Score: 0.055
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.